Waldenström Macroglobulinemia and Treatment Advancements with the Use of BTK Inhibitors | PTCE Pharmacy Connect
Pharmacy Times Continuing Education™ (PTCE) provides industry-leading pharmacy CE to retail, oncology, managed care, specialty, and health-system pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
Podcast 1: Waldenström Macroglobulinemia and Treatment Advancements with the Use of BTK Inhibitors
Educational Objectives
· Outline the pathophysiology of Waldenström macroglobulinemia (WM) and its connection to use of new and emerging drug therapies
· Review clinical guidelines and treatment selection in patients with WM
Faculty: Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist, Ambulatory Hematology Oncology
University of Michigan Rogel Cancer Center
Clinical Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan
Faculty has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-21-441-H01-P. The activity is available for CE credit through June 13, 2022.
This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc; and BeiGene, Ltd.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Podcast 1: Waldenström Macroglobulinemia and Treatment Advancements with the Use of BTK Inhibitors
Educational Objectives
· Outline the pathophysiology of Waldenström macroglobulinemia (WM) and its connection to use of new and emerging drug therapies
· Review clinical guidelines and treatment selection in patients with WM
Faculty: Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist, Ambulatory Hematology Oncology
University of Michigan Rogel Cancer Center
Clinical Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan
Faculty has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-21-441-H01-P. The activity is available for CE credit through June 13, 2022.
This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc; and BeiGene, Ltd.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Activity